This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Aparajita Lath In January, the Federal Trade Commission (FTC) released a new draft rule that would categorically ban non-compete clauses — contractual terms between an employer and an employee that prevent subsequent employment at a competing firm — across the country.
It provides tailored legal and regulatory support to patients, researchers, businesses, and incubators, driving progress in healthcare and biotechnology. Legal challenges and fragmented regulations are holding back the potential of personalized medicine. In Nature Medicine , we recently explored practical technical and legal solutions.
What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,
IBM and Google) to biotechnology (e.g., Second, even if a license isn’t granted, Moderna’s public promise justified reliance by others, and Moderna is thus prevented from retracting that promise under the doctrine of “promissory estoppel.” Tesla and Toyota) to software (e.g, According to the U.S. Why Should We Care?
These apps provide a window into some of the key issues in the world of digital health — including data privacy, data access, data ownership, bias, and the regulation of health technology. Direct-to-consumer (DTC) health apps, such as apps that manage our diet, fitness, and sleep, are becoming ubiquitous in our digital world.
The EU AI Act: A Blueprint for Safe AI Systems The EU’s AI Act , enacted in March 2024, sets a new benchmark for AI regulation with a risk-based classification system—ranging from unacceptable to minimal risk—that dictates stringent safety measures and upholds fundamental rights.
In the context of an organization like Gather Well—namely, a recent extension of a lineage that has failed to prevent, and even enabled, harm—bioethicists taking on ethics consultancies face complex challenges. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.
The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so. The FTC can also make rules to help prevent data breaches before they occur, and is in fact moving towards formal rulemaking in consumer privacy. Turning to the FTC?
A global public good refers to something that everyone can access (“nonexcludable”) and whose use by one does not prevent use by others (“nonrivalrous”). This delays the time before a generic drug or biosimilar can get approved, by blocking regulators from using the first applicant’s clinical data for the approval of competitors’ versions.
Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. She discussed additional relevant neuroscience concepts, such as structural changes in gray matter and cortical thickness, and changes in personality and self-regulation.
The COVID-19 pandemic has laid bare the lack of regulation for the sharing of intellectual property (IP) and technology needed for an effective and equitable response to the crisis. The COVID-19 pandemic demonstrates that it is difficult to regulate the open sharing of IP/know-how and technology while a global health emergency is unfolding.
To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. A full video of the event is available below.
Many of these developments are predicated on data and AI algorithms to prevent, diagnose, treat, and monitor sources of epidemic diseases, such as the ongoing pandemic and other pathogenic outbreaks.
It is not intended to treat, diagnose, cure, or prevent disease. CFR – code of federal regulations 21. Electronic Code of Federal Regulations. 9] Electronic Code of Federal Regulation. Medicinal and Aromatic Plant Science and Biotechnology, 3(1):90-93. [16] Electronic Code of Federal Regulation.
He and his collaborators had “ forged ethical review documents and misled doctors into unknowingly implanting gene-edited embryos into two women ” in deliberate violation of national regulations on biomedical research and medical ethics. He Jiankui’s Controversial Comeback Fast forward to the present.
8] In the near future, policy changes could result in developer consequences if proper actions are not taken to prevent algorithmic biases. [9] With innovation, there comes a lag in necessary regulation and policy changes. It is critical for clinicians and AI companies to work with regulators like the FDA to agree upon adaptations.
SEF in Israel – Social context and policy Israel’s social egg freezing regulation ( amended in 2022 to allow more eggs to be retrieved and more treatment cycles), allows the eggs of healthy women aged 30-41 to be frozen. This post considers these debates with a focus on the Israeli context. The procedure is not publicly funded.
Stigma prevents marginalized people from communicating their fertility struggles to their communities, families, and sometimes even to their partners. Imposing a medical certificate or appointment card as a formality might present a more significant barrier to this entitlement for vulnerable groups.
Many of these household products actually include flame retardants, chemicals added to materials to prevent or reduce the spread of fire. Her research interests include genetics, environmental health sciences, novel biotechnologies, and the FDA regulatory process. At HLS, Jessica is co-president of the Harvard Health Law Society.
Recalling the increasing recurrence of public health emergencies over the past century and contemplating the possibility of the continued proliferation of emergencies, the Principles clarify human rights law obligations and standards applicable in prevention of, preparation for, response to, and recovery from, such emergencies.
Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.
The legal and institutional regime aimed at preventing and controlling the spread of infectious diseases, grounded on the International Health Regulations (IHR) was heavily criticized. This could facilitate preparedness, preventive action, and dedication of resources, which could avert an escalation of the situation.”.
This could prevent patients from accessing treatments that improve on or offer different benefits from existing therapies, even when the new drug and existing drug are completely unrelated. Startups adds the concern that biotechnology startups need genus protection to attract early-stage funding and acquisitions. The Alliance of U.S.
Daar explains how regulations protecting embryos could potentially restrict IVF, focusing on issues around embryo discard, cryopreservation, preimplantation genetic testing, and selective reduction. Judith Daar on the future of IVF in a post- Dobbs U.S.
In fact, our current legal guidelines prevent anyone from truly owning our genes. On Intellectual Property and Lingering Discomforts The notion that we may not own the information that comes from our cells and genes is not as disenfranchising as it sounds.
The Principles affirm States’ obligations to cooperate towards measures that prepare for, prevent and respond to public health emergencies. She concludes that “strong, well-coordinated and resilient public health care services play a vital role in preventing and responding to public health crises.” Ahmed et al.
Business is bustling for biotechnology and biomanufacturing. On September 12, 2022, President Biden signed an executive order , launching a “whole-of-government approach to advance biotechnology and biomanufacturing.” Biotechnologyregulation. By Matthew Chun. Bio-related data set development and management.
Conventional negligence theory suggests that since it is likely a lab leak will happen, and reasonably foreseeable that microorganisms will escape (perhaps one engineered to infect humans), reasonable preventive measures are indicated. So, what could those be? Other countries have not been as diligent. appeared first on Bill of Health.
Regulating bisphenols , a class of endocrine disrupting chemicals, has been challenging due to “ regrettable substitution. Regulating bisphenols , a class of endocrine disrupting chemicals, has been challenging due to “ regrettable substitution. BPA is one of many Endocrine Disrupting Chemicals (EDCs).
Such a provision could prevent the public from paying twice for publicly-funded medical products—first through their taxes subsidizing government funded research and development, and second to procure the product in an inflated U.S. Moreover, the NASDAQ Biotechnology Index increased by 374% from 1995 to 2000. pharmaceutical market.
Moreover, while many scientists, regulators , and members of the public have called for societal discourse or consensus related to individual reproductive genetic innovation techniques, these calls rarely include an explanation as to how these discourses would be conducted.
Ivor Campbell, CEO of Snedden Campbell The global landscape for medical technology, biotechnology, and life sciences is on the cusp of seismic change. The confluence of geopolitical tensions, economic uncertainty, and evolving social values has created a complex web of challenges and opportunities for these sectors around the world.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content